Vascular Biogenics Ltd reports results for the quarter ended in September - Earnings Summary

Notable Labs

15/11/2021 14:32

* Vascular Biogenics Ltd  VBLT.OQ  reported a quarterly adjusted
loss of 9 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 11 cents per share.
* Revenue rose 3.1% to $199.00 thousand from a year ago; 
analysts expected $150.00 thousand. 
* Vascular Biogenics Ltd's reported EPS for the quarter was a
loss of 9 cents​.
* The mean earnings estimate of analysts had fallen by
about 1.4% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Vascular Biogenics Ltd shares had risen by 23.4% this
quarter and gained 33.9% so far this year.
* The company reported a quarterly loss of $6.5 million.
* Wall Street's median 12-month price target for Vascular
Biogenics Ltd is $5.25 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 02:31 p.m.
 ​All figures in US dollars unless otherwise stated